AI built in the service of science, from knowledge graph to drug discovery
This is our editors' assessment out of 5, not an average of user ratings. The viewpoints on this page are written by AI from what we know about the product. They are not customer reviews.
According to OpenAITools.app telemetry verified on 2026-11-11, BenevolentAI (benevolent.ai) is an AI platform indexed under AI Healthcare generating 0 monthly visits with a month-over-month traffic delta of +0 (0%). Its primary geographic market is Global (— traffic share), and it operates on a Contact for Pricing pricing model. Top competing alternatives by monthly volume include Connected Papers (750.58K visits/mo), Dr.Oracle (723.85K visits/mo), Intelligencia AI (3.87K visits/mo).
Invaluable knowledge graphs for our drug discovery pipeline.
Solid biomedical intelligence platform.
Enterprise pricing is steep but worth it.
Revolutionizing target identification.
AI-synthesized perspectives grounded in live site inspection, pricing structure, and category benchmarks — presented as editorial viewpoints rather than individual customer testimonials.
A decade of investment in a proprietary biomedical knowledge graph and ontologies that structure scientific data for machine learning.
Apply AI and machine learning to identify and prioritise promising drug targets and mechanisms.
An always-on strategic function that turns life science data into insight for biopharma decision makers and consultancies.
Teams of scientists and engineers work with partners to embed cutting-edge AI into real R&D workflows.
BenevolentAI is a biopharma technology company that applies advanced artificial intelligence to the discovery of new medicines and to life science intelligence. Its foundation is a decade-long investment in a proprietary biomedical knowledge graph and set of ontologies, which give machine learning models a structured, curated view of scientific knowledge to reason over.
The company brings together science and technology teams who work with partners to embed AI into real drug-discovery workflows — from hypothesis generation and target identification to prioritising mechanisms worth pursuing. BenevolentAI also offers Qor, an always-on strategic function that helps biopharma decision makers and life science consultancies draw insight from scientific data.
BenevolentAI is headquartered in Luxembourg and listed on Euronext Amsterdam under the ticker BAI. Because its work is enterprise-focused, access and scope are arranged directly with the company rather than through self-serve plans.
Use AI-driven knowledge graphs and machine learning to surface and prioritise promising targets for drug programmes.
Tap Qor for always-on strategic insight drawn from life science data to inform research and portfolio choices.
Bring structured biomedical AI capability into client projects without building a knowledge graph in-house.
Leverage curated ontologies and knowledge-graph tooling to make sense of large volumes of scientific literature and data.
Side-by-side telemetry comparison of competing AI tools in the same primary category
| Rank | AI Tool | Monthly Visits | MoM Growth | Direct traffic share | Pricing | Head-to-Head |
|---|---|---|---|---|---|---|
| ● | BenevolentAI | 0 | 0% | — | Contact for Pricing | Current |
| 1 | Connected Papers | 750.58K | +3.1% | 41% direct | Freemium | vs Connected Papers |
| 2 | Dr.Oracle | 723.85K | -1.2% | 12% direct | Free Trial | vs Dr.Oracle |
| 3 | Intelligencia AI | 3.87K | -31.9% | 27% direct | Contact for Pricing | vs Intelligencia AI |
| 4 | Cradle | 16.99K | -22.3% | 37% direct | Contact for Pricing | vs Cradle |
| 5 | Insight | 2.76K | -2.7% | 39% direct | Free | vs Insight |
| 6 | InfraNodus | 62.93K | -9.9% | 30% direct | Freemium, Free Trial | vs InfraNodus |
Free / Open-sourceExplore the academic literature as a visual graph of related papers
Free / Open-sourceExplore the academic literature as a visual graph of related papers
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians
AI-powered probability-of-success analytics for clinical drug development
AI-powered probability-of-success analytics for clinical drug development
Engineer better proteins, faster, with AI
Free / Open-sourceAI research assistant for medical literature, hypotheses, and study design
Free / Open-sourceAI research assistant for medical literature, hypotheses, and study design
Free / Open-sourceAI text analysis with knowledge graphs to reveal topics and content gaps
Free / Open-sourceAI text analysis with knowledge graphs to reveal topics and content gaps
Free / Open-sourceAI-powered visual discovery of scientific knowledge
Free / Open-sourceAI-powered visual discovery of scientific knowledge
AI-enabled literature review and evidence management platform trusted by top pharma and medical device teams
AI-enabled literature review and evidence management platform trusted by top pharma and medical device teams
Free / Open-sourceMake sense of peptides with research-backed AI guidance
Free / Open-sourceMake sense of peptides with research-backed AI guidance
SpecialistGraph context layer that turns unstructured enterprise knowledge into traceable AI answers
SpecialistGraph context layer that turns unstructured enterprise knowledge into traceable AI answers
Causal AI and Gemini Digital Twins for next-generation drug discovery
Causal AI and Gemini Digital Twins for next-generation drug discovery
Targeted research audiences with AI-verified data quality
Targeted research audiences with AI-verified data quality
